INDEX. Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS

Size: px
Start display at page:

Download "INDEX. Performance Improvement Program in Surgical Pathology SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS"

Transcription

1 INDEX SURVEYS 2012 AND ANATOMIC PATHOLOGY EDUCATION PROGRAMS Performance Improvement Program in Surgical Pathology

2 PIP CASE SUMMARY INDEX Breast Angiosarcoma 86% Tubular adenoma 97% Medullary carcinoma 97% Phyllodes tumor 95% Infiltrating lobular carcinoma 87% Adenoid cystic carcinoma 95% Lobular carcinoma in situ 86% Tubular adenoma 88% Infiltrating ductal carcinoma 88% Low grade cystosarcoma phyllodes 96% Silicone granuloma 94% Papillary carcinoma 83% Ductal hyperplasia without atypia 67% Well differentiated adenocarcinoma 60% Phyllodes tumor 66% Sarcoma 89% Metaplastic carcinoma 92% Lipid rich carcinoma 65% Infiltrating mammary carcinoma, NOS 24% Hyperplasia, lobular, atypical (Kodachrome) 56% Lactating adenoma 93% Ductal carcinoma in situ, comedo-type 91% Silicone reaction (silicone granuloma) 89% Infiltrating ductal carcinoma breast 59% Invasive lobular carcinoma of the breast, pleomorphic type 98% Cystosarcoma phyllodes with sclerosing liposarcoma 88% Lactating adenoma, breast 87% Ductal carcinoma in situ, low grade 80% Colloid carcinoma (mucinous carcinoma) 99% Adenomyoepithelioma 76% Infiltrating lobular carcinoma 88% Ductal carcinoma in situ 72% Infiltrating ductal carcinoma of no special type 84% Undifferentiated carcinoma 28% Invasive ductal carcinoma of no special type, grade III/III 94% Benign phyllodes tumor 79% Invasive micropapillary carcinoma 93% Myofibroblastoma 87% Phyllodes tumor 87% Metaplastic carcinoma 85% Metaplastic carcinoma 95% Sarcomatoid carcinoma (metaplastic carcinoma) 94% Malignant phyllodes tumor 99% Infiltrating duct carcinoma, poorly differentiated 96% Invasive lobular carcinoma 98% Pseudoangiomatous stromal hyperplasia 97% Phyllodes tumor, low grade 90%

3 Cardiovascular Giant cell myocarditis 94% Temporal arteritis (giant cell arteritis) 99% Granulomatous myocarditis 71% Acute cellular rejection, moderate 16% Eosinophilic myocarditis 97% Vasculitis, histologically compatible with polyarteritis nodosa 72% Cardiac myxoma 97% Severe acute cellular rejection and chronic vasculopathy 69% Cardiac hemosiderosis 48% Cardiac myxoma 98% Endocrine Parathyroid adenoma 94% Hashimoto thyroiditis 89% Follicular lesion (follicular neoplasm) of thyroid 73% Papillary thyroid carcinoma 71% Malignant pancreatic endocrine tumor (islet cell) 86% Adrenal cortical adenoma 62% Medullary carcinoma 94% Pheochromocytoma 90% Primary parathyroid hyperplasia 88% Paraganglioma 81% Nodular goiter 91% Adrenal cortical carcinoma 90% Papillary carcinoma 85% Follicular carcinoma, insular type 65% Parathyroid adenoma 96% Hashimoto thyroiditis 65% Brown tumor of hyperparathyroidism 85% Papillary carcinoma 99% Angioinvasive follicular carcinoma 37% Adrenal cortical carcinoma 83% Anaplastic carcinoma 78% Pheochromocytoma (composite variant) 96% Follicular thymic hyperplasia 90% Medullary carcinoma 84% Hürthle cell papillary adenoma 65% Adrenal pseudocyst 87% Myelolipoma 88% Parathyroid adenoma 92% Chronic lymphocytic thyroiditis - slide unavailable (data can not be calculated) Diffuse toxic goiter 70% Medullary thyroid carcinoma 94% Pheochromocytoma 95% Precursor T-cell acute lymphoblastic lymphoma 95% Myelolipoma 95% Hashimoto thyroiditis, fibrous variant 86% Paraganglioma 92% Graves Disease (diffuse toxic goiter) 88% Papillary carcinoma (NOS, usual type) 49% Pheochromocytoma 96% Solid-pseudopapillary tumor 78% Extranodal marginal zone B-cell (MALT) lymphoma 78% Hürthle cell carcinoma 65%

4 Endocrine Ganglioneuroma 96% Neuroblastoma, poorly differentiated 69% Undifferentiated (anaplastic) carcinoma 97% Adrenal cortical carcinoma 89% Myelolipoma 95% Papillary carcinoma, classical type 80% Undifferentiated (anaplastic) carcinoma 97% Follicular variant of papillary carcinoma 97% Autoimmune (Hashimoto) thyroiditis 99% Adrenal cortical carcinoma 87% Carcinoma with thymus-like elements 86% Pheochromocytoma 98% Medullary carcinoma 99% Acinar cell carcinoma 96% Neuroblastoma, poorly differentiated 89% Pancreatic neuroendocrine tumor 96% Solid-pseudopapillary neoplasm 97% Gastrointestinal Hyperplastic polyp 90% Cloacogenic carcinoma, basaloid type, of anal canal 99% Stromal tumor (cellular leiomyoma) of stomach 90% Crohn disease of ileum 98% Familial adenomatous polyposis coli 99% Villous adenoma 90% Carcinoid tumor of the appendix 92% Crohn disease of colon 86% Helicobacter pylori gastritis 66% Ulcerative colitis 64% Adenocarcinoma of stomach, diffuse type (linitis plastica) 98% Adenocarcinoma of colon, moderately to poorly differentiated grade II/III 77% Leiomyosarcoma of the stomach 75% Pseudomembranous colitis 99% Barrett's esophagus with dysplasia 89% Acute infectious colitis 86% Ulcerative colitis 95% Epithelioid leiomyoma of stomach 90% Ischemic colitis 94% Leiomyosarcoma of colon 94% Pneumatosis cystoides intestinales 95% Acute appendicitis 85% Barrett's esophagus 95% Mucinous adenocarcinoma of rectum 95% Microcystic adenoma 90% Diversion colitis 79% Crohn disease 83% Small cell carcinoma of the colon 82% Carcinoid tumor of small bowel 94% Malignant gastric stromal tumor 89% Collagenous colitis (kodachrome) 78% Adenocarcinoma, pancreas 53% Crohn disease 95% Solid-cystic papillary epithelial neoplasm, pancreas 61% Pancreatic endocrine tumor 76% Adenocarcinoma, cecum 62% Fibromatosis, small bowel 94% Acute self-limited colitis (infectious colitis) 54%

5 Gastrointestinal Malignant gastrointestinal stromal tumor N/A Cytomegalovirus colitis 66% Chronic active gastritis 80% Adenocarcinoma 93% Neutropenic enterocolitis (typhilitis) 73% Pneumatosis cystoides intestinalis 93% Inflammatory fibroid polyp 87% Microcystic adenoma 95% Pancreatoblastoma 91% Ischemic colitis 94% Hirschsprung's disease 90% Strongyloidiasis (autoinfection) 96% Peutz-Jeghers (hamartomatous) polyp 87% Familial polyposis 98% Crohn colitis 82% Adenocarcinoma 77% Ulcerative colitis 96% Acinar cell carcinoma 94% Cytomegalovirus esophagitis 82% Pancreatic endocrine tumor (gastrinoma) 90% Diffuse B-cell lymphoma (Gastric large cell lymphoma) 84% Eosinophilic gastroenteritis 99% Lymphocytic colitis 80% Basaloid squamous carcinoma 60% Clostridium difficile pseudomembranous colitis 98% Solid-pseudopapillary tumor 75% Gastrointestinal stromal tumor 91% Ductal adenocarcinoma 91% Inflammatory fibroid polyp 67% Malakoplakia 93% Invasive poorly differentiated adenocarcinoma with mucinous and signet ring cell features N/A Active chronic gastritis, Helicobacter pylori-associated (type B gastritis, chronic antral gastritis) 99% Pancreatic endocrine neoplasm (islet tumor) 84% Gastrointestinal stromal tumor, malignant 99% Active chronic colitis, severe, consistent with fulminant phase of chronic ulcerative colitis 57% Cytomegalovirus colitis 90% Serous microcystic adenoma 97% Adenocarcinoma, intestinal type 74% Adenocarcinoma, primary 82% Ischemic colitis 81% Teratoma 94% Adenocarcinoma of gallbladder 87% Signet-ring carcinoma 82% Burkitt lymphoma 83% Pseudomembranous colitis 98% Mixed carcinoid-adenocarcinoma 98% Bacillary angiomatosis 71% Adenocarcinoma 92% Melanoma 60% Metastatic renal cell carcinoma 99% Mucinous cystic neoplasm (mucinous cystadenoma) 95% Pancreatic endocrine carcinoma - 97% Adenocarcinoma of the small bowel, arising in celiac disease 74% Microcystic serous cystadenoma 97% Crohn disease 99% Mucinous carcinoma arising in an intraductal papillary mucinous neoplasm 92%

6 Gastrointestinal Gastrointestinal stromal tumor 99% Lymphoepithelial cyst 88% Plasmacytoma 99% Adenocarcinoma, diffuse (signet ring cell) type 96% Sclerosing mesenteritis 96% Acinar cell carcinoma 92% Solid pseudopapillary neoplasm 98% Ulcerative colitis 94% Pseudomembranous colitis secondary to Clostridium difficile infection 98% Pneumatosis (cystoides) intestinalis related to progressive systemic sclerosis 91% Crohn disease 96% Well-differentiated pancreatic endocrine tumor 90% Medullary carcinoma 80% Multicystic peritoneal mesothelioma 95% Clostridium difficile pseudomembranous colitis 98% Mucinous adenocarcinoma 86% Epithelioid trophoblastic tumor 88% Microcystic serous cystadenoma 98% Collagenous colitis 96% Gastrointestinal stromal tumor 97% Mesenteric fibromatosis 94% Sclerosing mesenteritis 94% Neuroendocrine tumor, WHO grade 2 92% Burkitt lymphoma 97% Genetic Familial adenomatous polyposis 99% Tumoral calcinosis 96% Wilson Disease 97% Gynecologic Ovary, clear cell adenocarcinoma 95% Uterus, hydatidiform mole (partial or complete) 88% Endodermal sinus tumor (yolk sac tumor) 97% Serous cystadenoma of low malignant potential 82% Sclerosing stromal tumor 63% Endometrium, late secretory 92% Endometrioid adenocarcinoma of ovary 92% Serous papillary carcinoma of endometrium 50% Simple hyperplasia of the endometrium 45% Chorioamnionitis 98% Placental infarct 82% Sertoli-Leydig cell tumor, poorly differentiated 58% Mucinous carcinoma of low malignant potential 69% Term diamniotic, monochorionic twin placenta 86% Villitis of unknown etiology 69% Leiomyosarcoma 46% CIN III 95% Adenocarcinoma of endometrium 78% Müllerian adenosarcoma of 41% Malignant mesothelium of peritoneum 93% Juvenile granulosa cell tumor of ovary 84% Mature (solid) teratoma 52% Cystadenofibroma of ovary 74% Endometrioid adenocarcinoma 70%

7 Gynecologic Brenner tumor of ovary 90% Carcinosarcoma of endometrium 81% Adnexal tumor of probable Wolffian origin 74% Clear cell carcinoma 83% 93-K2 Simple endometrial hyperplasia 16% Endometrioid carcinoma of the ovary 70% Serous borderline tumor 88% Granulosa cell tumor 96% Immature teratoma, high grade 77% Metastatic colonic adenocarcinoma 53% Chorangioma 98% Granular cell tumor 97% Adenocarcinoma endometrioid, grade III 60% Listeria monocytogenes 88% Lichen sclerosis w/ squamous cell hyperplasia 71% Dysgerminoma 97% Small cell carcinoma 75% Massive diffuse perivillous fibrinoid deposition 64% Mucinous adenoma 91% Myxoid leiomyosarcoma 76% Adenosarcoma 73% Luteoma of pregnancy 86% Uterine papillary serous carcinoma 82% Acute chorioamnionitis 95% Cellular fibroma 35% Metastatic gastric adenocarcinoma 66% Endometrioid tumor of low malignant potential 49% Necrotizing funisitis due to congenital syphilis 89% Sertoli-Leydig cell tumor intermediate-to-poorly differentiated 78% Yolk sac tumor 95% Endometrial stromal sarcoma high grade 73% Adenomatoid tumor 87% Complex endometrial hyperplasia with atypia 74% Hyperreactor luteinalis 86% Borderline (proliferating) Brenner tumor 81% Parvovirus B19 fetopathy with hydrops fetalis 69% Acute lymphoblastic leukemia 28% Serous borderline tumor (serous tumor of low malignant potential) 92% Partial hydatidiform mole 72% Primary transitional cell carcinoma 37% Sex cord tumor with annular tubules 49% Partial hydatidiform mole 72% Primary peritoneal papillary serous carcinoma, low grade 76% Thecoma 37% Clear cell carcinoma 92% Sertoli-Leydig cell tumor w/ granulosa cell tumor and heterologous elements 56% Malignant mixed Müllerian tumor, heterologous type 97% Mucinous tumor of borderline malignancy 96% Low grade endometrial stromal sarcoma with sex cord elements 57% Dysgerminoma 90% Small cell carcinoma 93% Adult granulosa cell tumor 94% Lymphoplasmacytic villitis due to cytomegalovirus infection 74% Pregnancy luteoma 39% Acute bacterial villitis 92% Sclerosing stromal tumor 67% Carcinoid tumor 79%

8 Gynecologic Brenner tumor 87% Endometrioid carcinoma 62% Adenocarcinoma 70% Epithelioid leiomyoma 83% Immature teratoma 90% Mature cystic teratoma 95% Liposarcoma wit myxoid features 72% Hydatidiform mole, complete 82% Endocervical adenomyoma 74% Epithelioid trophoblastic tumor 32% Yolk sac tumor (endodermal sinus tumor) 76% Listeria monocytogenes infection 91% Fallopian tube adenocarcinoma 71% Chorangiomatosis 50% Sertoli-Leydig cell tumor 55% Serous borderline cystadenofibroma 71% Adult granulosa cell tumor 89% Endometrial polyp 85% Metastatic pancreatic adenocarcinoma 65% Leiomyosarcoma 90% Aggressive angiomyxoma 97% Fibroma 87% Juvenile granulosa cell tumor 85% Clear cell carcinoma 62% Mucinous borderline tumor 67% Metastatic gastric carcinoma 77% Mature teratoma 89% Yolk sac tumor (endodermal sinus tumor) 94% Stromal carcinoid 95% Endometrial stromal tumor with sex-cord like elements 89% Serous carcinoma, high grade 91% Acute villitis 73% Ovarian small cell carcinoma, hypercalcemic type 50% Hydrops placentalis 78% Sex cord tumor with annular tubules 72% Carcinosarcoma (malignant mixed Müllerian tumor) 52% Endometrioid adenocarcinoma 56% Brenner tumor 99% Adult granulosa cell tumor 95% Sclerosing stromal tumor 75% Lipoleiomyoma 97% Endometrial stromal sarcoma, low grade 93% Epithelioid leiomyosarcoma 30% Malignant mixed Müllerian tumor 61% Clear cell carcinoma 94% Hepatoid carcinoma 74% Embryonal rhabdomyosarcoma with anaplasia 89% Juvenile granulosa cell tumor 96% Metastatic colorectal adenocarcinoma 98% Chronic villitis secondary to cytomegalovirus infection 98% Serous neoplasm of low malignant potential 95% High grade endometrioid carcinoma, grade 3 94% Endometrial stromal sarcoma, low grade 98% Endometrioid adenocarcinoma 96% Myeloid sarcoma 94% Yolk sac tumor 99% Complete hydatidiform mole 92%

9 Gynecologic Myxoid/round cell liposarcoma 97% Steroid cell tumor, not otherwise specified 89% Adult granulosa cell tumor 93% Dysgerminoma 97% Endometrioid adenocarcinoma 98% Chronic villitis secondary to cytomegalovirus infection 89% Complete hydatidiform mole 93% Complete hydatidiform mole 97% Juvenile granulosa cell tumor 95% Benign Brenner tumor 96% Müllerian adenosarcoma 81% Angiomyofibroblastoma 93% Sclerosing stromal tumor 96% Dysgerminoma 98% Cellular fibrothecoma 87% Endometrial stromal sarcoma 99% Mesenchymal dysplasia 87% Dysgerminoma 99% Head & Neck Heme/Lymphatic Mucoepidermoid carcinoma 97% Warthin's tumor 99% Pleomorphic adenoma (benign mixed tumor) 89% Squamous cell carcinoma of larynx 86% Adenoid cystic carcinoma 96% Benign lymphoepithelial lesion of parotid gland 78% Acinic cell adenocarcinoma 87% Allergic fungal sinusitis 64% Low grade adenocarcinoma (nasopharyngeal papillary adenocarcinoma) 84% Cystic nonkeratinizing squamous cell carcinoma, metastatic to neck lymph node 64% Carcinoma ex-mixed tumor 75% Pleomorphic adenoma 91% Squamous papilloma 89% Acinic cell adenocarcinoma 73% Synovial sarcoma, monophasic 86% Warthin tumor 99% Spindle cell lipoma 69% Extraosseous plasmacytoma 99% Acinic cell carcinoma 99% Basaloid squamous cell carcinoma 97% Reactive follicular hyperplasia, non-specific 97% Diffuse small lymphocytic lymphoma (well-differentiated) 89% Follicular small cleaved cell (nodular poorly differentiated lymphocytic) lymphoma 96% Reactive lymph node hyperplasia 93% Hodgkin disease, nodular sclerosing type 99% Metastatic lobular breast carcinoma in lymph node 91% Diffuse large cell lymphoma 95% Diffuse large cell lymphoma, non-cleaved 50% Metastatic malignant melanoma 66% Cat scratch disease 98% Encapsulated thymoma 75% Carcinoid of the thymus 92% Melanoma in lymph node 87% Nodular lymphoma 68% Castleman's disease 95% Hodgkin disease, nodular sclerosing 95% Hodgkin disease, nodular sclerosing 88%

10 Heme/Lymphatic Burkett lymphoma 91% Malignant lymphoma, non-hodgkin, small non-cleaved cell 78% Large cell malignant lymphoma 74% Malignant lymphoma, mantle cell type 48% Hodgkin disease 88% Hodgkin disease, nodular sclerosis type 99% Malignant lymphoma, diffuse large cell type 73% Hairy cell leukemia of the spleen 91% Idiopathic thrombocytopenia purpura 88% Malignant lymphoma, follicular 60% Malignant lymphoma, MALT type, low grade 63% Castleman's disease 91% Lymphocyte-predominant thymoma 87% Malignant lymphoma, small non-cleaved cell type 57% Thymoma, epithelial predominant (cortical) 95% Malignant lymphoma, mantle cell type, cecum 30% Malignant lymphoma large cell type 57% Marginal zone/malt lymphoma 77% Thymic carcinoma 71% Hodgkin disease, mixed cellularity type 78% Hepatosplenic γδ T-cell lymphoma 82% Extramedullary hematopoiesis of spleen in agnogenic myeloid metaplasia 90% Malignant lymphoma, diffuse, mixed small cleaved and large cell type 72% Infectious mononucleosis 74% Littoral cell angioma 59% Primary amyloidosis, lymph node 66% Prolymphocytic leukemia 40% Anaplastic large cell lymphoma 83% Angiosarcoma, spleen 46% Lymphocyte predominant Hodgkin lymphoma 63% Multiple myeloma 87% Splenic involvement by small lymphocytic lymphoma/chronic lymphocytic N/A Cat scratch disease 96% Extramedullary myeloid tumor 50% Carcinoid tumor consistent with thymic origin 93% Hairy cell leukemia 96% Nodular sclerosis Hodgkin disease 94% Langerhans cell histiocytosis 92% Mantle cell lymphoma 89% Follicular lymphoma 84% Hodgkin lymphoma, nodular sclerosis type 88% Hepatosplenic T-cell lymphoma 86% Mantle cell lymphoma 83% Small lymphocytic lymphoma 88% Typical carcinoid 72% Littoral cell angioma 78% Diffuse large B-cell lymphoma (anaplastic variant) 95% Follicular lymphoma 95% Myeloid sarcoma ( chloroma ) 90% Systemic mastocytosis 93% Classical Hodgkin lymphoma 92% Inflammatory myofibroblastic tumor 94% Acute myeloid leukemia 39% Gaucher disease 92% Thymic carcinoid 97% Angiosarcoma 88% Hepatosplenic T-cell lymphoma 96%

11 Heme/Lymphatic Splenic marginal zone lymphoma Angiofollicular hyperplasia (Castleman disease) 96% Lymphoepithelial thymoma 96% Lymphangioma 85% Paraganglioma 96% Hairy cell leukemia 97% Littoral cell angioma 97% Spindle cell thymoma (WHO type A) 92% Lymphangioma (Lymphatic malformation) 96% Mantle cell lymphoma 83% Low grade fibromyxoid sarcoma with giant collagen rosettes 95% Hairy cell leukemia 97% Niemann-Pick disease 85% Nodular sclerosis classical Hodgkin lymphoma 97% Diffuse large B-cell lymphoma, NOS 98% Viral associated hemophagocytic syndrome 98% Splenic marginal zone lymphoma 91% Follicular dendritic cell sarcoma 97% Gaucher disease 99% Amyloidosis 99% Intra-abdominal desmoplastic small round cell tumor 98% Hepatosplenic T-cell lymphoma 85% Mantle cell lymphoma 99% Hepatobiliary Hepatocellular cellular carcinoma 94% Micronodular cirrhosis, etiology uncertain 97% Focal nodular hyperplasia 93% Chronic passive congestion 99% Primary biliary cirrhosis 71% Focal nodular hyperplasia 91% Hepatocellular carcinoma 95% Cirrhosis 75% Primary sclerosing cholangitis 11% Hepatoblastoma 94% Chronic active hepatitis 89% Hepatocellular carcinoma 27% Acute acetaminophen hepatotoxicity 90% Biliary cystadenoma with mesenchymal stroma 95% Cholangiocarcinoma 78% Fibrolamellar carcinoma 86% Chronic hepatitis C, with mild activity (grade 2) & mild periportal (stage 2) 91% Budd-Chiari syndrome 74% Liver cell adenoma 80% Angiosarcoma 69% Mesenchymal hamartoma 89% Epithelial hepatoblastoma, mixed fetal and embryonal types 39% Fibrolamellar hepatocellular carcinoma 90% Recurrent pyogenic cholangitis 65% Adenocarcinoma 93% Acute myeloid leukemia 93% Amyloidosis 98% Chronic rejection 81% Liver cell carcinoma 80% Primary biliary cirrhosis 92% Embryonal (undifferentiated) sarcoma 89% Hepatocellular adenoma 61%

12 Hepatobiliary Hepatobiliary cystadenoma 60% Focal nodular hyperplasia 91% Mesenchymal hamartoma 98% Congenital hepatic fibrosis 78% Metastatic hemangiopericytoma 58% Focal nodular hyperplasia 83% Hepatoblastoma 93% Mastocytosis 89% Polycystic liver disease 72% Cirrhosis due to alpha-1-antitrypsin deficiency 75% Amyloidosis with biliary-type fibrosis 96% Herpes simplex virus hepatitis 73% Submassive hepatic necrosis 64% Hepatoblastoma 89% Fibrolamellar hepatocellular carcinoma 94% Aggressive systemic mastocytosis 93% Focal nodular hyperplasia 98% Angiosarcoma 95% Cavernous hemangioma 99% Herpes simplex virus hepatitis 95% Hepatocellular carcinoma 98% Alpha-1-antitrypsin deficiency 96% Hepatocellular carcinoma 99% Cholesterolosis 99% Cavernous hemangioma 95% Fibrolamellar carcinoma 97% Congenital hepatic fibrosis 95% Biliary cirrhosis secondary to cystic fibrosis 96% Glycogen storage disease, type IV 97% Hepatoblastoma 99% Alcoholic liver disease with cirrhosis 99% Hepatitis C with alpha-1-antitrypsin intracytoplasmic globules 99% Focal nodular hyperplasia 97% Mesenchymal hamartoma 96% Fibrolamellar hepatocellular carcinoma 99% Angiosarcoma 98%

13 Male Genital Granulomatous prostatitis, non-specific 95% Basal cell hyperplasia of the prostate 96% Granulomatous orchitis (autoimmune orchitis) 90% Cryptorchid testis 95% Seminoma 90% Malignant lymphoma, diffuse, large cell 85% Teratocarcinoma 97% Adenocarcinoma 95% 92-K1 Prostatic adenocarcinoma 69% Idiopathic granulomatous orchitis 87% Seminoma 93% Mixed germ cell neoplasm 68% Sertoli cell adenoma, arising in a patient with complete androgen insensitivity syndrome 73% High grade prostatic intraepithelial neoplasia 91% Adenomatoid tumor 97% Spermatocytic seminoma, testis 77% Immature teratoma, testis 80% Seminoma 96% Spermatocytic seminoma 95% Seminoma 97% Aggressive angiomyxoma 81% Leydig cell tumor 97% Primary testicular lymphoma, diffuse large B-cell type 95% Seminoma 98% Stromal tumor of uncertain malignant potential 88% Nervous System Aggressive angiomyxoma 92% Glioblastoma multiforme (astrocytoma grade III-IV) 98% Meningioma 99% Alzheimer's disease 93% Cerebral infarct, recent, mixed anemic and hemorrhagic 97% Neuroblastoma 95% Oligodendroglioma 55% Ganglioneuroblastoma 84% Transitional meningioma 98% Papillary meningioma 62% Cytomegalovirus ventriculitis 84% HIV encephalitis 65%? Progressive multifocal leukoencephalopathy 67% Cryptococcal meningitis 92% Primary CNS lymphoma 93% Ganglioneuroblastoma, recurrent, lumbar epidural space and retroperitoneum (neuroblastoma also accepted) 83% Acute demyelinating process 58% Dementia with Lewy bodies 32% Subependymal giant cell astrocytoma 85% Cerebral amyloid angiopathy 85% Human prion disease: Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease) 2% Histoplasmosis 74% Gliomatosis cerebri 88% Pilocytic astrocytoma 90% Progressive multifocal leukoencephalopathy 91% Central neurocytoma 72% Aggressive angiomyxoma 92% Oligodendroglioma, WHO grade III 87%

14 Nervous System Desmoplastic infantile astrocytoma/ganglioma 79% Schwannoma 78% Differentiating neuroblastoma 75% Fibrous meningioma 93% West Nile encephalitis 80% Choroid plexus carcinoma 63% Intravascular lymphoma 92% Ependymoma 88% Microcystic meningioma 62% Recurrent high grade astrocytoma with gemistocytic features (WHO grade III-IV) 85% Gliomatosis cerebri (WHO grade III) 85% Paraganglioma of the cauda equine 82% Atypical meningioma (WHO grade II) 33% Pituitary adenoma 98% Chordoid meningioma 95% Anaplastic hemangiopericytoma of the nervous system 90% Gliomatosis cerebri 91% Cortical tuber associated with tuberous sclerosis 88% Malignant peripheral nerve sheath tumor 96% Chordoid meningioma, WHO grade II 95% Oral Path Ameloblastoma 94% Odontogenic keratocyst 53% Central giant cell granuloma 94% Peripheral ossifying fibroma 42% Dentigerous follicular cyst 80% Mucocele 98% Oral lichen planus 85% Ameloblastoma 92% Premalignant epithelial dysplasia 54% Adenoid cystic carcinoma 88% Respiratory Normal lung (kodachrome, FNA) 78% Small cell carcinoma 94% Adenocarcinoma with numerous tumor giant cells 99% Spindle cell variant of squamous cell carcinoma 95% Adenocarcinoma, moderately differentiated 97% Bronchiolo-alveolar carcinoma 79% Pneumocystic carinii pneumonia 98% Squamous cell carcinoma 83% Kaposi sarcoma 96% Measles pneumonia (giant cell pneumonia) with severe diffuse alveolar damage 59% Diffuse alveolar damage 93% Oat cell carcinoma 95% Carcinoid tumor 69% Acute interstitial pneumonia 30% Malignant mesothelioma of pleura 96% Coccidioidomycosis 94% Adenocarcinoma, poorly differentiated 47% Broncho-alveolar adenocarcinoma 77% Actinomycosis 87% Microcystic adenoma 91% Diffuse septal amyloidosis 67% Pulmonary cryptococcosis 93% Acute interstitial pneumonia 46%

15 Respiratory Localized fibrous tumor of pleura 91% Granulomatous lung disease, NOS 65% Adenosquamous carcinoma 75% Giant cell interstitial pneumonia 60% Low grade pleuropulmonary blastoma 25% Herpes simplex pneumonia 73% Solitary fibrous tumor, pleura 82% Malignant mesothelioma, tubulopapillary type 96% Intralobar pulmonary sequestration 86% Silicosis 70% Pulmonary lymphangioleiomyomatosis 85% Pulmonary coccidioidomycosis 84% Kaposi sarcoma 86% Inflammatory myofibroblastic tumor 94% Wegener s granulomatosis 91% Epithelioid hemangioendothelioma 44% Cystic fibrosis 90% Legionella pneumonia 74% Respiratory syncytial virus pneumonia 69% Bronchioloalveolar adenocarcinoma 96% Peripheral primitive neuroectodermal tumor 89% Pulmonary hyperplasia 32% Solitary fibrous tumor 94% Lymphangioleiomyomatosis 89% Thymoma 94% Small cell carcinoma 55% Extranodal marginal zone (MALT) lymphoma 89% Bronchiectasis 82% Pulmonary amyloidosis, diffuse parenchymal type 92% Biphasic pulmonary blastoma 90% Cytomegalovirus pneumonia 85% Bronchioloalveolar carcinoma, mucinous type 92% Solitary fibrous tumor 95% Thymoma 90% Bronchioloalveolar carcinoma, mucinous type 93% Acute lobar pneumonia 86% Malignant solitary fibrous tumor 94% Pulmonary cryptococcosis 91% Follicular dendritic cell tumor/sarcoma 92% Cytomegalovirus pneumonia and Pneumocystis pneumonia 92% Small cell carcinoma 82% Pulmonary adenocarcinoma, mixed subtype 83% Extranodal marginal zone lymphoma, MALT type 98% Squamous cell carcinoma 95% Lymphangioleiomyomatosis 98% Cryptococcosis 98% Recurrent respiratory papillomatosis 93% Alveolar capillary dysplasia 85% Invasive mucinous adenocarcinoma 93% Extranodal marginal zone B-cell lymphoma 99%

16 Skin Pilomatrixoma (calcifying epithelioma of malherbe) 97% Malignant melanoma 81% Congenital nevus 79% Dermatofibrosarcoma protuberans 87% Merkel cell tumor 79% Peripheral neuroectodermal tumor 63% Proliferating trichilemmal cyst 85% Giant congenital melanocytic nevus 80% Extramammary Paget s disease 87% Atypical nevus with mild dysplasia 81% Malignant melanoma 79% Warty dyskeratoma 82% Desmoplastic trichoepithelioma 62% Extramammary Paget s disease 97% Discoid lupus erythematous 90% Cutaneous blastomycosis 84% Merkel cell carcinoma 95% Epithelioid and spindle cell nevus 88% Endometriosis 95% Angiosarcoma 97% Angiosarcoma 93% Condyloma acuminatum 96% Angiosarcoma 87% Nodular melanoma 97% Soft Tissue/Bone/Joint Epithelioid sarcoma 98% Parosteal osteosarcoma 86% Paget's disease 96% Ewing sarcoma 93% Extra abdominal desmoid tumor (fibromatosis) 95% Rheumatoid synovitis 99% Aneurysmal bone cyst 85% Chondrosarcoma 84% Fibrous dysplasia 86% Synovial sarcoma, monophasic 79% Malignant fibrous histiocytoma 86% Lipoma, intramuscular 10% Schwannoma 95% Liposarcoma, high grade 71% Nodular fascitis 90% Myxoid liposarcoma 84% Pleomorphic lipoma/well-differentiated liposarcoma 61% Elastofibroma 89% Rheumatoid nodule 92% Malignant fibrous histiocytoma, storiform-pleomorphic type 87% Well-differentiated liposarcoma 72% Angiolipoma 71% Fibrous dysplasia 59% Schwannoma (neurilemmoma) 65% Lymphangiomyoma 90% Biphasic synovial sarcoma 57% Aggressive angiomyxoma 81% Embryonal rhabdomyosarcoma 85% Osteoarthritis 82% Angiosarcoma 90% Chondrosarcoma 52%

17 Soft Tissue/Bone/Joint Avascular necrosis, osteonecrosis 97% Inflammatory myofibroblastic tumor 89% Intramuscular myxoma 93% Leiomyomatosis peritonealis disseminata 96% Alveolar soft part sarcoma 43% Amyloid tumor 95% Neurofibroma 95% Myxoid/round cell liposarcoma 90% Rhabdomyoma, adult type 90% Chronic synovitis consistent with rheumatoid arthritis 44% Pleomorphic leiomyosarcoma 65% Giant cell fibroblastoma with dermatofibrosarcoma protuberans 68% Chordoma 43% Schwannoma (neurilemmoma), soft tissue 85% Elastofibroma, subscapular area 90% Diffuse malignant mesothelioma 88% Pigmented villonodular synovitis 97% Synovial sarcoma, right parietal pleura 41% Osteosarcoma with grade IIB treatment effect 82% Malignant fibrous histiocytoma 94% Neuroblastoma, poorly differentiated 15% Malignant mesothelioma 21% Desmoid tumor (abdominal fibromatosis) 93% Diffuse neurofibroma 75% Fibrous hamartoma of infancy 89% Extranodal Rosai-Dorfman disease 56% Alveolar soft part sarcoma 93% Myxoid liposarcoma 90% Rhabdomyosarcoma with treatment effect 67% Spindle cell lipoma 84% Multicystic mesothelioma, peritoneum 94% Granular cell tumor of soft tissue 97% Cerebral abscess 89% Myositis ossificans 82% Meningothelial meningioma 85% Extra-abdominal fibromatosis (desmoid tumor) 54% Myxopapillary ependymoma of the filum terminale 71% Hibernoma 96% Juxta-articular myxoma 78% Giant cell tumor 91% Granulomatous inflammation due to Coccidioidomycosis (C. immitis) 65% Clear cell myomelanocytic tumor of hepatic falciform ligament/ligamentum 68% Castleman disease 96% Malignant peripheral nerve sheath tumor 87% Monophasic synovial sarcoma 94% Chondrosarcoma 97% Sclerosing well-differentiated liposarcoma 72% Myxoid/round cell liposarcoma 66% Epithelioid hemangioendothelioma 34% Ewing sarcoma-pnet 94% Incontinentia pigmenti 71% Kimura Disease 93% Pleomorphic hyalinizing angiectatic tumor 95% Synovial chondromatosis 77% Perivascular epithelioid cell tumor (PEComa) 79% Infantile fibrosarcoma 83% Malignant solitary fibrous tumor 62%

18 Soft Tissue/Bone/Joint Elastofibroma 84% Lipoblastoma 82% Malignant peripheral nerve sheath tumor 92% Alveolar soft part sarcoma 95% Intramuscular myxoma 93% Plexiform neurofibroma 88% Myxoid liposarcoma 91% Spindle cell lipoma 94% Ewing sarcoma/primitive neuroectodermal tumor 92% Osteosarcoma 76% Alveolar soft part sarcoma 67% Post radiation osteosarcoma, fibroblastic type 96% Plasmacytoma, extramedullary 93% Metastatic melanoma 99% Angiomyofibroblastoma-like tumor of the male genital tract 84% Malignant mesothelioma 95% Desmoid-type fibromatosis 93% Chondrosarcoma 95% Mammary-type myofibroblastoma 65% Ganglioneuroma 97% Leiomyosarcoma 99% Myxoid liposarcoma 91% Metastatic mucinous adenocarcinoma (mucinous carcinoma peritonei) 97% Schwannoma with degenerative changes 86% Elastofibroma 95% Myxoma 98% Osteosarcoma, chondroblastic type 93% Angiosarcoma 97% Well-differentiated liposarcoma 90% Primary renal Ewing sarcoma/primitive neuroectodermal tumor 90% Intraosseous osteosarcoma, low-grade 87% Glomus tumor 98% Kaposiform hemangioendothelioma 92% Malignant mesothelioma 99% Synovial sarcoma 99% Chondrosarcoma, well-differentiated 96% Kimura lymphadenopathy 91% Infantile fibrosarcoma 92% Ewing sarcoma/primitive neuroectodermal tumor 98% PEComa 94% Intramuscular myxoma 96% Primary synovial chondromatosis 92% Solitary fibrous tumor 98% Castleman disease 99% Alveolar soft part sarcoma 98% Pigmented villonodular synovitis, diffuse-type 92% Paraganglioma 98% Plexiform neurofibroma 97% Hibernoma 99% Myelolipoma 98%

19 Urinary Oncocytoma (grade 1 granular cell neoplasm) 98% Renal cell carcinoma 62% Nephrogenic adenoma (urothelial metaplasia) 72% Mesoblastic nephroma 98% Wilms tumor 94% Xanthogranulomatous pyelonephritis 79% Papillary transitional cell carcinoma 95% Renal cell carcinoma 99% Renal cell carcinoma, sarcomatoid 86% Transplant rejection of kidney, acute 98% Papillary transitional cell carcinoma, non-invasive 87% Congenital mesoblastic nephroma 86% Renal cell carcinoma, chromophobe cell subtype 26% Renal allograft rejection, acute and chronic 57% 95-K2 Focal and segmental glomerulonephritis 78% Myeloma cast nephropathy 94% 96-K1 IGA nephropathy 92% Renal medullary carcinoma 64% Nephroblastoma (Wilms tumor), favorable histology 36% Ethylene glycol nephrotoxicity 80% Invasive transitional cell carcinoma 83% Xanthogranulomatous pyelonephritis 95% Metanephric adenoma 73% Clear cell carcinoma 99% Chromophobe renal cell carcinoma 82% Wilms tumor with diffuse anaplasia 68% Angiomyolipoma 85% Sarcomatoid renal cell carcinoma 78% Urothelial neoplasm of low malignant potential 70% Oncocytoma 91% Clear cell sarcoma 54% Renal cell carcinoma, unclassified 64% Leiomyosarcoma 89% Sarcomatoid urothelial carcinoma 78% Wilms tumor, blastema predominant 84% Pseudosarcomatous reactive myofibroblastic proliferation N/A Mixed epithelial and stromal tumor 40% Oncocytoma 93% Chromophobe renal cell carcinoma 87% Acute cellular rejection with mild chronic transplant nephropathy 78% Leiomyosarcoma 89% Collecting duct carcinoma 92% Embryonal rhabdomyosarcoma, NOS 89% Angiomyolipoma 95% Papillary urothelial carcinoma, low grade 84% Wilms tumor 89% Xanthogranulomatous pyelonephritis 96% Mucinous tubular and spindle cell carcinoma of kidney 51% Congenital mesoblastic nephroma, cellular type 70% Carcinoid tumor 91% Angiomyolipoma 99% Acute cellular allograft rejection 73% Metanephric adenoma 71% Low grade papillary urothelial carcinoma 62% Oncocytoma 96% Chromophobe renal cell carcinoma 97% Papillary renal cell carcinoma 87%

20 Urinary Mixed epithelial and stromal tumor 86% Clear cell renal cell carcinoma 94% Angiomyolipoma 85% Non-invasive papillary urothelial carcinoma 98% Chromophobe renal cell carcinoma 97% Renal cell carcinoma with sarcomatoid component 96% Wilms tumor, favorable histology 94% Renal medullary carcinoma 87% Congenital mesoblastic nephroma 96% Angiomyolipoma 99% Urothelial carcinoma 98% Oncocytoma 98%

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12 Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background

More information

MODERN IMMUNOHISTOCHEMISTRY

MODERN IMMUNOHISTOCHEMISTRY MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,

More information

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,

More information

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society

More information

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause. Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic

More information

日 本 病 理 学 会 中 国 四 国 支 部 学 術 集 会 ( 第 114 回 スライドカンファレンス) 診 断 投 票 結 果

日 本 病 理 学 会 中 国 四 国 支 部 学 術 集 会 ( 第 114 回 スライドカンファレンス) 診 断 投 票 結 果 日 本 病 理 学 会 中 国 四 国 支 部 学 術 集 会 ( 第 114 回 スライドカンファレンス) 診 断 投 票 結 果 平 成 26 年 6 月 14 日 高 知 大 学 医 学 部 臨 床 講 義 棟 第 3 講 義 室 S2509 頬 粘 膜 腫 瘍 *Speaker's diagnosis Solitary fibrous tumor 12 Solitary fibrous tumor

More information

Immunohistochemical differentiation of metastatic tumours

Immunohistochemical differentiation of metastatic tumours Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in

More information

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer

More information

Pathology of lung cancer

Pathology of lung cancer Pathology of lung cancer EASO COURSE ON LUNG CANCER AND MESOTHELIOMA DAMASCUS (SYRIA), MAY 3-4, 2007 Gérard ABADJIAN MD Pathologist Associate Professor, Saint Joseph University Pathology Dept. Hôtel-Dieu

More information

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

This module consists of four units which will provide the user a basic knowledge of cancer as a disease. Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define

More information

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD Victor E. Reuter, MD Memorial Sloan-Kettering Cancer Center reuterv@mskcc.org 66 th Annual Pathology Seminar California Society of Pathologists Short

More information

Immunohistochemistry of soft tissue tumors

Immunohistochemistry of soft tissue tumors Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,

More information

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied

More information

List of Qualifying Conditions

List of Qualifying Conditions List of Qualifying Conditions Cancer Conditions 1) Adrenal cancer 2) Bladder cancer 3) Bone cancer all forms 4) Brain cancer 5) Breast cancer 6) Cervical cancer 7) Colon cancer 8) Colorectal cancer 9)

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

Co-pay assistance organizations offering assistance

Co-pay assistance organizations offering assistance Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin

More information

NATIONAL INSTITUTES OF HEALTH National Cancer Institute. Neoplasms

NATIONAL INSTITUTES OF HEALTH National Cancer Institute. Neoplasms NATIONAL INSTITUTES OF HEALTH National Cancer Institute to Neoplasms CONVERSION of NEOPLASMS BY TOPOGRAPHY AND MORPHOLOGY from the INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY, SECOND EDITION

More information

Anatomic Pathology Page 1 of 34

Anatomic Pathology Page 1 of 34 Anatomic Pathology Page 1 of 34 Anatomic Pathology Major Category Code Headings Revised 9/2014 I Anatomic Pathology Management 30000 II General Pathology Principles 30030 III Breast 30040 IV Male genital

More information

LCD for Erythrocyte Sedimentation Rate (ESR)

LCD for Erythrocyte Sedimentation Rate (ESR) LCD for Erythrocyte Sedimentation Rate (ESR) Applicable CPT Code(s): 85651 Sedimentation Rate, Erythrocyte; Non-Automated 85652 Sedimentation Rate, Erythrocyte; Automated ICD-9 Codes that Support Medical

More information

Chapter I Overview Chapter Contents

Chapter I Overview Chapter Contents Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality

More information

BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST BIOBANK LE-NIE HEST athologist :. BUTORI 12/09/2013 LE / HU Unit atient : N LH13-3603 N LB 13-0691 ID : RO A onsent : YES Age : 54 Diagnosis and staging : chronic pleuresia 5x1000µL BIOBANK LE-NIE HEST

More information

The menstrual cycle Hypophysis

The menstrual cycle Hypophysis Normal endometrium Tumors of the uterine corpus by MB The endometrium comprises the zona functionalis zf (superficial two thirds) ) and the zona basalis zb (deep one third) The zf responds to hormonal

More information

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there Friend for Life Cancer Support Network Annual Report 2010 Facing cancer, with someone who s been there This is wonderful support for those of us who are newly diagnosed with cancer. Our Mission To help

More information

Oncology Best Practice Documentation

Oncology Best Practice Documentation Oncology Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Solid Tumors Lymphomas Leukemias Myelodysplastic Syndrome Pathology Findings

More information

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses

THE PATHOLOGY OF MEDIASTINAL MASSES. Anatomic Distribution of Mediastinal Masses Page 1 of 5 THE PATHOLOGY OF MEDIASTINAL MASSES Dr. S. Boag 549-6666 Ext. 4190, mailto:%20boag@cliff.path.queensu.ca 1. INTRODUCTION A wide range of process, neoplastic and non-neoplastic, can produce

More information

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic

More information

ADOPTED REGULATION OF THE STATE BOARD OF HEALTH. LCB File No. R075-98. Effective November 18, 1998

ADOPTED REGULATION OF THE STATE BOARD OF HEALTH. LCB File No. R075-98. Effective November 18, 1998 ADOPTED REGULATION OF THE STATE BOARD OF HEALTH LCB File No. R075-98 Effective November 18, 1998 EXPLANATION Matter in italics is new; matter in brackets [ ] is material to be omitted. AUTHORITY: 2-13,

More information

190.25 - Alpha-fetoprotein

190.25 - Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

Pediatric Oncology for Otolaryngologists

Pediatric Oncology for Otolaryngologists Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department

More information

INDEX. in this web service Cambridge University Press. References to Figures are in bold.

INDEX. in this web service Cambridge University Press. References to Figures are in bold. References to Figures are in bold. AAH (atypical adenomatous hyperplasia) 124 125 abscesses 33, 35 amebic 48 ACC (adenoid cystic carcinoma) 179, 179 180, 180, 181 acinar adenocarcinoma 126 127 moderately

More information

History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter.

History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter. FRCPath Part 2 Histopathology Examination Histology short cases Commentary. Case 1. History. Female age 64. Tumour right kidney on scan. Partial nephrectomy. Tumour 18mm diameter. Diagnosis: Angiomyolipoma

More information

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

NEOPLASMS C00 D49. Presented by Jan Halloran CCS NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through

More information

PROTOCOL OF THE RITA DATA QUALITY STUDY

PROTOCOL OF THE RITA DATA QUALITY STUDY PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of

More information

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Lung Cancer Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine Alexandria, Egypt July 1-1 3, 2008 OBJECTIVES Describe and

More information

Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin

Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Rodney T. Miller, M.D. Director of Immunohistochemistry ProPath Laboratory 1355 River Bend Drive Dallas, TX 75247-4915

More information

FRCPath Part 2 Histopathology Short Cases, autumn 2014

FRCPath Part 2 Histopathology Short Cases, autumn 2014 FRCPath Part 2 Histopathology Short Cases, autumn 2014 Commentary Case 1 Female age 52: palpable lesion, left breast Breast, fat necrosis. Average: 2.6/5 This case was chosen as a good example of fat necrosis

More information

Leukemias and Lymphomas: A primer

Leukemias and Lymphomas: A primer Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes

More information

Systemic Health: Pathology

Systemic Health: Pathology Page 1 Systemic Health: Pathology A. General Health 2. Detailed history with regards to differential diagnosis of fatigue, weight loss, fever, headache, dizziness, and malaise 3. Presentations involving

More information

Frozen Section Diagnosis

Frozen Section Diagnosis Frozen Section Diagnosis Dr Catherine M Corbishley Honorary Consultant Histopathologist St George s Healthcare NHS Trust and lead examiner final FRCPath Practical 2008-2011 Frozen Section Diagnosis The

More information

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS LEARNING OBJECTIVES At the end of the lecture, students should be able to: Know the pathology of renal tumors. RENAL TUMORS RENAL PAPILLARY ADENOMA Common

More information

Gynecology Abnormal Physiology of the ovaries. Simple Cystic Masses

Gynecology Abnormal Physiology of the ovaries. Simple Cystic Masses Gynecology Abnormal Physiology of the ovaries (Effective February 2007) pediatric, reproductive, and perimenopausal/postmenopausal (24-28 %) Simple Cystic Masses ovary s function is to mature oocytes until

More information

CHAPTER 4 Specific tumor sites (part 1)

CHAPTER 4 Specific tumor sites (part 1) CANCER REGISTRATION HANDBOOK CHAPTER 4 Specific tumor sites (part 1) Contents IV(1)-2 IV(1)-2 IV(1)-3 IV(1)-3 IV(1)-3 IV(1)-3 IV(1)-4 IV(1)-4 IV(1)-7 IV(1)-7 IV(1)-7 IV(1)-8 IV(1)-8 IV(1)-8 IV(1)-9 IV(1)-9

More information

Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern

Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern Common Morphologic Patterns in Soft Tissue Tumors John R. Goldblum, M.D. Chairman, Department of Anatomic Pathology The Cleveland Clinic Professor of Pathology Cleveland Clinic Lerner College of Medicine

More information

Something Old, Something New.

Something Old, Something New. Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan

More information

NLSY79 ATTACHMENT 8: HEALTH CODES

NLSY79 ATTACHMENT 8: HEALTH CODES NLSY79 ATTACHMENT 8: HEALTH CODES 1 GENERAL INFORMATION ON HEALTH CODES The health section of the NLS survey elicits health problems that limit the amount or kind of work the respondent can do. Those health

More information

Nuno Morais 1 José António Moreira da Costa 2

Nuno Morais 1 José António Moreira da Costa 2 Nuno Morais 1 José António Moreira da Costa 2 1 Neurosurgery Department, Hospital de Braga, Braga, Portugal 2 Private Practice, Clínica Neurológica e da Coluna Vertebral, Braga, Portugal Disclosure Funding

More information

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma

More information

PathMD: Board Review Letter TM

PathMD: Board Review Letter TM Questions 1. Mantle Cell Lymphoma is associated with which of the following: A. t(11;14) B. t(8;14) C. t(2;5) D. t(11;18) E. t(14;18) 2. A case of anaplastic large cell lymphoma (ALCL) with t(1;2) is stained

More information

A guide to cancer types and chemotherapy medications

A guide to cancer types and chemotherapy medications A guide to cancer types and chemotherapy medications This guides lists words that mean cancer, cancer types and intravenous chemotherapy medications. If you have any questions, see page 10 for details

More information

The Patient Access Network (PAN) Foundation Eligibility Diseases Targeted Contact Information

The Patient Access Network (PAN) Foundation Eligibility Diseases Targeted Contact Information The Patient Access Network (PAN) Foundation is an independent non-profit organization that provides assistance to underinsured patients for their out-of-pocket expenses through more than 40 disease-specific

More information

R-16: Chronic nonspecific cervisit

R-16: Chronic nonspecific cervisit R-16: Chronic nonspecific cervisit Ectoservikal squamous epithelium Endoservical columnar epithelium Dilated cystic endoservical glands lymphoplasmocytes R18:Squamous cell carcinoma insitu Neoplastic epithelium

More information

ARTICOLO DI AGGIORNAMENTO IN PATOLOGIA DELLE PARTI MOLLI

ARTICOLO DI AGGIORNAMENTO IN PATOLOGIA DELLE PARTI MOLLI PATHOLOGICA 2006;98:239-298 CONOSCERE PER RICONOSCERE THE EYE WILL RECOGNIZE WHAT THE MIND ALREADY KNOWS UPDATING ARTICLE IN SOFT TISSUE PATHOLOGY ARTICOLO DI AGGIORNAMENTO IN PATOLOGIA DELLE PARTI MOLLI

More information

Cardiac Masses and Tumors

Cardiac Masses and Tumors Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:

More information

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours

Diseases. Inflammations Non-inflammatory pleural effusions Pneumothorax Tumours Pleura Visceral pleura covers lungs and extends into fissures Parietal pleura limits mediastinum and covers dome of diaphragm and inner aspect of chest wall. Two layers between them (pleural cavity) contains

More information

Grossing & Intraoperative Evaluation Boot Camp

Grossing & Intraoperative Evaluation Boot Camp AP RTC July 2011 Moffitt: HSW- 532 Zion: B2 Conf. Room MON TUES WED THURS FRI Grossing & Intraoperative Evaluation Boot Camp 4 5 6 Lymph node & general principles in gross pathology - Grossing principles

More information

SEER SINQ s. Finalized March 2011

SEER SINQ s. Finalized March 2011 ized March 2011 : 20110067 First course treatment--heme & Lymphoid Neoplasms: Are the treatment guidelines in the "red book" still valid? See discussion. While I realize that the Hematopoietic Database

More information

World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone

World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone World Health Organization Classification of Tumours WHO OMS International Agency for Research on Cancer (IARC) Pathology and Genetics of Tumours of Soft Tissue and one Edited by Christopher D.M. Fletcher

More information

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct)

Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Service Definition with all Clinical Terms Service: Laprascopic Cholecystectomy Clinic (No Gallstones in bile duct) Section 1 Service Details Service ID: 7540540 Service Comments: Referrer Alert: Service

More information

Non-Hodgkin s Lymphoma

Non-Hodgkin s Lymphoma Non-Hodgkin s Lymphoma Luis Fayad, MD Assistant Professor Clinical Medical Director Lymphoma/Myeloma Department Non-Hodgkin s Lymphoma Non-Hodgkin s lymphomas (NHL) are a heterogeneous group of malignant

More information

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:

More information

Multiple Primary and Histology Coding Rules

Multiple Primary and Histology Coding Rules Multiple Primary and Histology Coding Rules January 10, 2008 National Cancer Institute Surveillance Epidemiology and End Results Program Bethesda, MD PLEASE NOTE This PDF of the 2007 Multiple Primaries

More information

Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu

Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Table of Contents Page Undifferentiated panel 1 CK7/20 table 2 Breast carcinoma

More information

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT NCCN guidelines were reviewed on 3/25/2013 for utilization of 18 F-fluorodeoxyglucose (FDG) PET and PET/CT (available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp).

More information

Cancer and how your policy works. General & Medical

Cancer and how your policy works. General & Medical Cancer and how your policy works General & Medical This booklet, like others in our information book series are designed to help you understand the various aspects of General & Medical private healthcare

More information

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd. Emerging Subtypes in Renal Cancer Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.edu Some General Comments Fuhrman nuclear grading clear cell

More information

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Renal tumours WHO 4 MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER Molecular differential pathology of renal cell tumours G. KOVACS A CLASSIFICATION BASED ON UNDERSTANDING THE GENETIC

More information

Pleural and Chest Wall Tumors

Pleural and Chest Wall Tumors Pleural and Chest Wall Tumors Ritu Gill, MD, MPH Dr. Ritu R. Gill Department t of Radiology Brigham and Women s Hospital Harvard Medical School CLASSIFICATION OF CHEST WALL TUMORS Primary neoplasm of chest

More information

Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1

Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1 Immunohistochemistry of clear cell tumours J. Klos MD Department of Pathology Stavanger University Hospital Norway What are clear cell tumours? Multiple factors in etiology of clear cell changes: - technical

More information

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues Ovarian mucinous lesions Ovarian mucinous lesions: Common diagnostic dilemmas Karuna Garg, MD University of California San Francisco Intestinal or usual type Seromucinous (Endocervical mucinous or Mullerian

More information

Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701)

Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701) Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701) Contractor Information Contractor Name Cahaba Government Benefit Administrators, LLC Article Information General Information

More information

The develpemental origin of mesothelium

The develpemental origin of mesothelium Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal

More information

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver

Oncology. Topic-Bile Duct Carcinoma. Topic-Adenocarcinoma, Lung. Topic-Hemangiosarcoma, Spleen and Liver Topic-Adenocarcinoma, Lung Figure 1. Pulmonary adenocarcinoma. Figure 2. Pulmonary bronchiolar carcinoma. Figure 3. Pulmonary fibrosarcoma. Topic-Adenocarcinoma, Skin (Sweat Gland, Sebaceous) Figure 1.

More information

Description Code Recommendation Description Code. All natural death 001-799 IPH All natural death A00-R99

Description Code Recommendation Description Code. All natural death 001-799 IPH All natural death A00-R99 Natural death Description Code Recommendation Description Code All natural death 001-799 IPH All natural death A00-R99 Infectious and parasitic diseases 001-139 CDC, EUROSTAT, CBS & VG Infectious and parasitic

More information

Today s Topics. Tumors of the Peritoneum in Women

Today s Topics. Tumors of the Peritoneum in Women Today s Topics Tumors of the Peritoneum in Women Charles Zaloudek, M.D. Department of Pathology 505 Parnassus Ave., M563 University of California, San Francisco San Francisco, CA USA charles.zaloudek@ucsf.edu

More information

page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9)

page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) New IHC Antibodies 2 Table of Contents page antibody 1 2 3 4 5 6 7 8 Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) Caveolin-1 (2297) CD13 (SP187) CD16 (SP175)

More information

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Outline. Workup for metastatic breast cancer. Metastatic breast cancer Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30

More information

General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung

General Thoracic Surgery ICD9 to ICD10 Crosswalks. C34.11 Malignant neoplasm of upper lobe, right bronchus or lung ICD-9 Code ICD-9 Description ICD-10 Code ICD-10 Description 150.3 Malignant neoplasm of upper third of esophagus C15.3 Malignant neoplasm of upper third of esophagus 150.4 Malignant neoplasm of middle

More information

Effusions: Mesothelioma and Metastatic Cancers

Effusions: Mesothelioma and Metastatic Cancers Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,

More information

Common Cancers & Hereditary Syndromes

Common Cancers & Hereditary Syndromes Common Cancers & Hereditary Syndromes Elizabeth Hoodfar, MS, LCGC Regional Cancer Genetics Coordinator Kaiser Permanente Northern California Detect clinical characteristics of hereditary cancer syndromes.

More information

DELRAY MEDICAL CENTER. Cancer Program Annual Report

DELRAY MEDICAL CENTER. Cancer Program Annual Report DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions

More information

Local Coverage Determination (LCD): Immunohistochemistry (L34369)

Local Coverage Determination (LCD): Immunohistochemistry (L34369) Local Coverage Determination (LCD): Immunohistochemistry (L34369) Contractor Information Contractor Name CGS Administrators, LLC LCD Information Document Information LCD ID L34369 Original ICD9 LCD ID

More information

Ovarian masses - CT imaging

Ovarian masses - CT imaging Dr. Sujata Patnaik Review Article Ovarian masses - CT imaging Sujatha Patnaik 1 1 Department of Radiology, Nizam s Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India *Corresponding author:

More information

INFLAMMATORY PLEURAL EFFUSION

INFLAMMATORY PLEURAL EFFUSION PLEURA- LESIONS LESIONS OF PLEURA Primary Intra pleural bacterial infections Neoplasm (mesothelioma) Secondary A complication of some underlying disease PLEURAL EFFUSION Common manifestation of both primary

More information

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information.

A. Pericardial smear. Examination of the pericardial aspirate can provide useful diagnostic information. 5. PERICARDIUM Heart is encased by the pericardium which has a visceral layer (a) covering the heart and the parietal layer (b). In normal states it is thin, transparent and the myocardium can be seen

More information

Histopathology of Major Salivary Gland Neoplasms

Histopathology of Major Salivary Gland Neoplasms Histopathology of Major Salivary Gland Neoplasms Sam J. Cunningham, MD, PhD Faculty Advisor: Shawn D. Newlands, MD, PhD Faculty Advisor: David C. Teller, MD The University of Texas Medical Branch, Department

More information

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used? Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or

More information

Pathology of the Female Peritoneum, Common and Uncommon Problems

Pathology of the Female Peritoneum, Common and Uncommon Problems Pathology of the Female Peritoneum, Common and Uncommon Problems An Update on Gynecologic Pathology Florence, Italy Anaís Malpica, M.D. Professor of Pathology Pathology of the Female Peritoneum Keratin

More information

Primary -Benign - Malignant Secondary

Primary -Benign - Malignant Secondary TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low

More information

H. Fibrous tumors. 17. Intravascular papillary endothelial hyperplasia. 1. Soft fibroma. To Order, Visit the Purchasing Page for Details

H. Fibrous tumors. 17. Intravascular papillary endothelial hyperplasia. 1. Soft fibroma. To Order, Visit the Purchasing Page for Details Go Back to the Top To Order, Visit the Purchasing Page for Details lesion appears suddenly, forms erosion and bleeds. Pyogenic granuloma should be differentiated from amelanotic melanoma. Pathologically,

More information

BIOBANK LPCE-NICE CHEST

BIOBANK LPCE-NICE CHEST BIOBANK LE-NIE HEST athologist : S. LASSALLE 01/03/2011 Time for frozen procedure : 10 mn LE / HU Unit atient : N LH 11-0004 N LB 11-0002 onsent : YES Age : 37 ID : TH ER Diagnosis and staging : Hodgkin

More information

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc. Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

More information

C a nc e r C e nter. Annual Registry Report

C a nc e r C e nter. Annual Registry Report C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases

More information

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital

More information

Diagnosis of Mesothelioma Pitfalls and Practical Information

Diagnosis of Mesothelioma Pitfalls and Practical Information Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com

More information

Spleen. Anatomy. (Effective February 2007) (1%-5%) Normal. Related Anatomy Anterior to spleen. Medial border. Posteriorly

Spleen. Anatomy. (Effective February 2007) (1%-5%) Normal. Related Anatomy Anterior to spleen. Medial border. Posteriorly Spleen (Effective February 2007) (1%-5%) Anatomy Normal Intraperitoneal, except hilum Left hypochondrium Left hemidiaphragm superior generally considered to be ovoid, with a convex superior and a concave

More information

SERIOUS ILLNESS COVER

SERIOUS ILLNESS COVER WITH OUR COVER YOU ARE MORE LIKELY TO GET A PAYOUT VITALITY.CO.UK/LIFE Vitality s Serious Illness Cover offers protection against serious illnesses as well as advanced or life threatening ones THE AVERAGE

More information

Compilation of Spontaneous Neoplastic Lesions and Survival in Crl:CD (SD) Rats from Control Groups

Compilation of Spontaneous Neoplastic Lesions and Survival in Crl:CD (SD) Rats from Control Groups Compilation of Spontaneous Neoplastic Lesions and Survival in Crl:CD (SD) Rats from Control Groups March, 2004 Information Prepared by Mary L.A. Giknis, Ph.D. Charles B. Clifford, D.V.M., Ph.D. CHARLES

More information

New Hampshire Childhood Cancer

New Hampshire Childhood Cancer Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children

More information